“‘Operation Warp Speed’ has pledged to deliver 300 million doses of a COVID-19 vaccine by 2021, if not sooner. The COVID-19 vaccines are all being rushed straight into human clinical tests, forgoing lengthy animal trials altogether. Such fast-tracked vaccines pose unknown risks, which are further magnified since governments are granting COVID-19 vaccine makers immunity from liability for all vaccine injuries and deaths that occur after the vaccines are recommended or mandated by public health officials. The main concern is that the combination of COVID-19 vaccines being fast-tracked to market at ‘warp speed’ with minimal testing, together with blanket liability protection against vaccine injuries could be a public health nightmare in the making. Early warning signs that something might be amiss have already started emerging. From Moderna’s Phase 1 human trial revealed 100% of volunteers in the high-dose group suffered systemic side effects. Past attempts at developing COVID vaccines have always faltered at this stage as both humans and animals achieved robust antibody response then sickened and died when exposed to the wild virus. Moderna allowed only exceptionally healthy volunteers to participate in the study. A vaccine with those reaction rates could cause grave injuries in 1.5 billion humans if administered to ‘every person on earth.’ As reported by NPR14 September 4, 2020, executives at Moderna have also cashed in stock options, raking in tens of millions of dollars of personal profit in the process. Since January, CEO Stéphane Bancel has sold roughly $40 million worth of Moderna stock held by himself or associated investment funds; Chief Medical Officer Tal Zaks has sold around $60 million; and President Stephen Hoge has sold more than $10 million. Advocates have questioned whether it’s appropriate for executives to privately profit before bringing the vaccine to market, especially when American taxpayers have committed roughly $2.5 billion to the company’s vaccine development and manufacture. Two Moderna executives, however, have sold all of their stock holdings, and its general counsel has sold ‘nearly all’ of hers, NPR reports. Importantly, NPR discovered that several of the executives appear to have made ‘questionable modifications to stock sale plans’ shortly before key announcements were made about the vaccine — in some cases just a single day ahead of the announcements. Why would executives unload their stocks before the vaccine is even launched? Do they suspect or know something has, or is about to go awry? As of right now, there’s no evidence whatsoever that the company’s novel vaccine will actually work, let alone be safe. What do Moderna execs know that we don’t?
~Dr. Joseph Mercola
~via Lew Rockwell